Formycon AG Adopts AI Tools for ~20% Efficiency Gain
Formycon AG is integrating AI-enabled eTMF and analytics into its biosimilar development process, with an internal assessment expecting approximately 20% efficiency improvements.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.